跳到主要內容

Chang Carmen 的 Form 4 申報

NeueHealth, Inc.(NEUE),2025/10/6 申報

申報編號
0001193125-25-232142
申報時間
2025/10/6 17:52 ET
交易日
2025/10/2
申報延遲
4 天
10b5-1 計畫
沒有勾選

這份申報列了 17 筆非衍生性交易、14 筆衍生性交易。公開市場賣出合計 $2.64 萬。交易後 4 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Chang CarmenCIK 0001746342董事、持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2025/10/2Common StockX行使價內選擇權取得+189,195$0.01+$1,891.95788,259間接重複申報
2025/10/2Common StockS賣出處分−280$6.75−$1,890787,979間接重複申報
2025/10/2Common StockM行使選擇權取得+372,255$0.01+$3,722.551,160,234間接重複申報
2025/10/2Common StockF扣股繳稅處分−551$6.75−$3,719.251,159,683間接重複申報
2025/10/2Common StockD交回公司處分−1,159,683–F3–0間接重複申報
2025/10/2Common StockX行使價內選擇權取得+189,195$0.01+$1,891.95488,982間接重複申報
2025/10/2Common StockS賣出處分−280$6.75−$1,890488,702間接重複申報
2025/10/2Common StockM行使選擇權取得+186,128$0.01+$1,861.28674,830間接重複申報
2025/10/2Common StockF扣股繳稅處分−276$6.75−$1,863674,554間接重複申報
2025/10/2Common StockD交回公司處分−674,554–F3–0間接重複申報
2025/10/2Common StockX行使價內選擇權取得+1,656,789$0.01+$16,567.891,656,789間接重複申報
2025/10/2Common StockS賣出處分−2,455$6.75−$16,571.251,654,334間接重複申報
2025/10/2Common StockX行使價內選擇權取得+607,536$0.01+$6,075.362,261,870間接重複申報
2025/10/2Common StockS賣出處分−900$6.75−$6,0752,260,970間接重複申報
2025/10/2Common StockM行使選擇權取得+124,085$0.01+$1,240.852,385,055間接重複申報
2025/10/2Common StockF扣股繳稅處分−182$6.75−$1,228.52,384,873間接重複申報
2025/10/2Common StockD交回公司處分−2,384,873–F3–0間接重複申報

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2025/10/2Common StockX行使價內選擇權處分−189,195$0.00$00間接重複申報
2025/10/2Common StockA公司授予取得+372,255–F7–372,255間接重複申報
2025/10/2Common StockM行使選擇權處分−372,255$0.00$00間接重複申報
2025/10/2Common StockX行使價內選擇權處分−189,195$0.00$00間接重複申報
2025/10/2Common StockA公司授予取得+186,128–F7–186,128間接重複申報
2025/10/2Common StockM行使選擇權處分−186,128$0.00$00間接重複申報
2025/10/2Common StockD交回公司處分−330,194–F3–0間接重複申報
2025/10/2Common StockD交回公司處分−509,780–F3–0間接重複申報
2025/10/2Common StockX行使價內選擇權處分−1,656,789$0.00$00間接重複申報
2025/10/2Common StockX行使價內選擇權處分−607,536$0.00$00間接重複申報
2025/10/2Common StockA公司授予取得+124,085–F7–124,085間接重複申報
2025/10/2Common StockM行使選擇權處分−124,085$0.00$00間接重複申報
2025/10/2Common StockD交回公司處分−550,323–F3–0間接重複申報
2025/10/2Common StockD交回公司處分−1,352,200–F3–0間接重複申報

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F3

Pursuant to the Agreement and Plan of Merger, dated as of December 23, 2024, by and among the Issuer, NH Holdings 2025, Inc. ("Parent") and NH Holdings Acquisition 2025, Inc. ("Merger Sub"), on October 2, 2025, Merger Sub merged with and into the Issuer with the Issuer surviving such merger as a wholly owned subsidiary of Parent (the "Merger"). Pursuant to rollover agreements entered into between certain of the Reporting Persons and NH Holdings 2025 SPV, L.P. ("Ultimate Parent"), Parent and Merger Sub, each share of the Issuer's Common Stock, Series A Convertible Perpetual Preferred Stock ("Series A Preferred Stock") and Series B Convertible Perpetual Preferred Stock ("Series B Preferred Stock") beneficially owned by the Reporting Persons was contributed to Ultimate Parent in exchange for limited partnership interests in Ultimate Parent. Each such share of the Issuer's Common Stock, Series A Preferred Stock and Series B Preferred Stock was then cancelled and ceased to exist.

表 I 有 3 筆、表 II 有 4 筆交易的價格引用這則附註。

F7

Warrants issued pursuant to the Warrantholders Agreement, dated September 30, 2025 between the Issuer and the holders listed on Schedule 1 thereto, and the Credit Agreement, dated August 4, 2023, as amended by that certain Incremental Amendment No. 1, dated as of October 2, 2023, that certain Incremental Amendment No. 2, dated as of April 8, 2024, that certain Amendment No. 3, dated as of June 21, 2024, that certain Amendment No. 4, dated as of October 29, 2024, and that certain Amendment No. 5, dated as of September 30, 2025, between the Issuer and the lenders thereto.

表 II 有 3 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)